BNA Scholars Design and Host "Brain Sciences Symposium" aimed at supporting Early Career Researchers from Underrepresented Backgrounds
13th January 2025
Dementia is the greatest health challenge of our century.
To date there is no way to prevent it or even slow its progression, and there is an urgent need to fill the knowledge gap in our basic understanding of the diseases that cause it.
The UK Dementia Research Institute (UK DRI) is the biggest UK initiative driving forward research to fill this gap.
Researchers at the UK Dementia Research Institute at King's College London are using innovative approaches to explore the biological mechanisms involved in neurodegenerative diseases. Their goal is to defeat dementia by uncovering vital new knowledge that will lead to the design of smarter diagnostics and effective treatments. The team aims to understand the fundamental biological processes involved in dementia at a molecular level - and to use that knowledge to design new ways to diagnose and treat disease more precisely.
The successful candidate will be part of a team testing viral vector gene therapy reagents aimed at treating amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD) on a commercially funded project.
The aim of the project is to optimise the dose and delivery of gene supplement and knock-down vectors in cellular and animal models of disease as proof of concept and efficacy for potential clinical application. Working with Professor Shaw the candidate will join a team of technicians and post-doctoral scientists analysing cells and tissues transduced with plasmid and vector constructs and quantify the effects on target gene expression. For in vivo work the candidate will perform stereotactic surgery to inject viral vectors into the brain and spinal cord of rodents. They will perform behavioural testing on these animals as defined by the protocol and sacrifice and harvest selected tissues after an appropriate interval. They will prepare tissues for histological sectioning, staining, imaging and quantitative analyses.
All experiments will be undertaken at a very high standard and all data treated with complete confidentiality.
The candidate will join a research group based within the UK Dementia Research Institute (DRI) centre that is embedded within the Department of Basic and Clinical Neuroscience at King’s College London (www.kcl.ac.uk/ioppn/depts/bcn/dri/lab-groups) within the Maurice Wohl Clinical Neuroscience Institute on the Denmark Hill campus. The DRI is a national consortium focused on cutting-edge dementia research funded by the Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK (www.ukdri.co.uk).
Key responsibilities
The above list of responsibilities may not be exhaustive, and the post holder will be required to undertake such tasks and responsibilities as may reasonably be expected within the scope and grading of the post.
Person specification
Essential criteria
Desirable criteria
This post is subject to an Occupational Health clearance.
To apply, please visit: https://www.kcl.ac.uk/jobs/077385-research-associate-gene-therapy-in-the-department-of-basic-and-clinical-neuroscience
For informal enquiries, please contact Professor Christopher Shaw <chris.shaw@kcl.ac.uk>